Global Biobanking Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Biobanking market size will reach 3,833.31 Million USD in 2025 and is projected to reach 6,240.52 Million USD by 2032, with a CAGR of 7.21% (2025-2032). Notably, the China Biobanking market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Biobanking refers to the collection, storage, and management of biological samples and associated data for research purposes. A biobank is an organized repository that houses a large collection of biological materials, such as blood, tissue, cells, DNA, and other bodily fluids, along with relevant clinical and demographic information. Biobanks play a crucial role in advancing biomedical research, as they provide researchers with valuable resources for studying diseases, understanding genetic variations, developing new diagnostic tests, and discovering potential therapeutic targets. These samples can be used for a wide range of research areas, including genomics, proteomics, metabolomics, and personalized medicine. The establishment and operation of a biobank involve several important considerations. Ethical and legal aspects, such as informed consent, privacy protection, and data security, are of utmost importance to ensure the proper handling and use of the stored samples and associated information. Biobanks also follow strict quality control and standardization protocols to maintain the integrity and reliability of the collected samples. Furthermore, collaboration and partnerships between biobanks, researchers, and healthcare institutions are crucial for sharing samples and data, enabling larger-scale studies and maximizing the impact of research findings. Biobanks can be categorized into different types based on their focus and scope. Population-based biobanks collect samples from a specific population or community to study diseases and their causes within that population. Disease-oriented biobanks focus on collecting samples related to a specific disease or condition, such as cancer or cardiovascular diseases. Virtual biobanks leverage existing biobanks by aggregating data and samples from multiple sources to provide a comprehensive resource for researchers. Overall, biobanking plays a vital role in biomedical research, facilitating discoveries, and advancements in understanding human health and disease. It provides researchers with access to well-characterized biological materials, fostering collaborations, and ultimately improving healthcare outcomes.

The major global suppliers of Biobanking include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries, Brooks Life Science, Tecan Group, QIAGEN, BD, Lifeline Scientific, Hamilton, So-Low, TTP Labtech, Biolife Solutions, DNA Genotek, Custom Biogenic Systems, LVL Technologies, BioRep, Qingdao Haier Biomedical, OriginCell, Dashoo, Jiangsu Kangcheng Baiao Biotechnology, Takara Bio, Jiangsu Kangcheng Baiao Biotechnology, Wuxi NEST Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Biobanking. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Biobanking market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Biobanking market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biobanking industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Biobanking Include:

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Qingdao Haier Biomedical

OriginCell

Dashoo

Jiangsu Kangcheng Baiao Biotechnology

Takara Bio

Jiangsu Kangcheng Baiao Biotechnology

Wuxi NEST Biotechnology

Biobanking Product Segment Include:

Equipment

Consumable

Biobanking Product Application Include:

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Biobanking Industry PESTEL Analysis

Chapter 3: Global Biobanking Industry Porter's Five Forces Analysis

Chapter 4: Global Biobanking Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Biobanking Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Biobanking Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Biobanking Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources